Multiple Myeloma News
Myeloma Crowd Newsroom
Feb 11, 2014

Myeloma Crowd on ABC 4 News Utah

Watch multiple myeloma survivors Jenny Ahlstrom and Liz Smith Nielsen discuss the launch of www.myelomacrowd.org on ABC 4 Utah news.

About Author

Jenny A

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical trials. Founder of Myeloma Crowd, Myeloma Crowd Radio and the CrowdCare Foundation.

Leave A Comment Cancel reply

MYELOMA CROWD RESEARCH INITIATIVE

BRINGING THE RIGHT TREATMENT TO THE PATIENT AT THE RIGHT TIME

Please Help Us Reach Our Goal

Donate Now

HealthTree Life With Multiple Myeloma

What is HealthTree® for Multiple Myeloma?

Jan 22, 2020

– – – January is Myeloma Crowd Month! In the coming weeks, we are highlighting each of our programs and how they can help you in your myeloma journey. Learn more about what we do and if you run into a question or concerns, please email info@crowdcare.org.

Multiple Myeloma News

A Single T Cell Therapy for All Cancers? British Researchers Make a Key Discovery.

Jan 20, 2020

Cardiff University researchers have discovered a new a new type of T cell that can kill a variety of cancers, with the hope of creating a general “one-size-fits-all” T cell therapy. CAR T cell therapy today is commonly “customized” for each cancer patient using their own T cells. A patient has their immune system cells […]

IMW Multiple Myeloma News Myeloma Clinical Trials

IMW 2019: The New GSK Antibody Drug Conjugate in Myeloma

Oct 02, 2019

An antibody drug conjugate is a type of immunotherapy being explored in multiple myeloma. Glaxo-Smith Klein is developing a new antibody drug conjugate in myeloma called Belantamab mafodotin (or “belmaf” for short). These drugs use the immune system to find the right myeloma-specific target and then drop a toxic payload in a targeted way. At […]

Get Started Today.

Find a Clinical Trial that's Right for You

Thanks to our site sponsors: